Xiaobo Yu

590 total citations
14 papers, 472 citations indexed

About

Xiaobo Yu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaobo Yu has authored 14 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Xiaobo Yu's work include MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (4 papers) and Cancer-related molecular mechanisms research (4 papers). Xiaobo Yu is often cited by papers focused on MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (4 papers) and Cancer-related molecular mechanisms research (4 papers). Xiaobo Yu collaborates with scholars based in China, Madagascar and Thailand. Xiaobo Yu's co-authors include Qiang Lin, Yongqian Shu, Hua Shen, Liwen Xiong, Zhihua Zhang, Jianxin Shen, Siriporn Jitkaew, Swati Choksi, Jin Sun and Fengming Yang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, PLoS Genetics and Gene.

In The Last Decade

Xiaobo Yu

14 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaobo Yu China	11	317	229	97	58	57	14	472
Shi‐Juan Mai China	15	375 1.2×	225 1.0×	133 1.4×	64 1.1×	48 0.8×	32	572
Dan‐Ming Wei China	11	271 0.9×	182 0.8×	59 0.6×	74 1.3×	34 0.6×	26	422
Kemin Wu China	10	318 1.0×	250 1.1×	65 0.7×	70 1.2×	55 1.0×	19	456
Jamsheed Javid Saudi Arabia	11	305 1.0×	219 1.0×	54 0.6×	35 0.6×	34 0.6×	45	439
Chung‐Chieh Wang Taiwan	13	215 0.7×	85 0.4×	127 1.3×	102 1.8×	85 1.5×	24	423
Sercan Ergün Türkiye	14	445 1.4×	413 1.8×	40 0.4×	35 0.6×	40 0.7×	43	643
Caixia Wang China	14	281 0.9×	168 0.7×	64 0.7×	103 1.8×	78 1.4×	30	491
Yue Gu China	13	477 1.5×	202 0.9×	82 0.8×	94 1.6×	26 0.5×	38	593
Yunpeng Jin China	10	406 1.3×	339 1.5×	63 0.6×	32 0.6×	76 1.3×	29	514

Countries citing papers authored by Xiaobo Yu

Since Specialization

Citations

This map shows the geographic impact of Xiaobo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Yu more than expected).

Fields of papers citing papers by Xiaobo Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Yu. The network helps show where Xiaobo Yu may publish in the future.

Co-authorship network of co-authors of Xiaobo Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo Yu. A scholar is included among the top collaborators of Xiaobo Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo Yu. Xiaobo Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Yu, Xiaobo, et al.. (2024). Salidroside inhibits the ferroptosis to alleviate lung ischemia reperfusion injury via the JAK2/STAT3 signalling pathway. Biochemical and Biophysical Research Communications. 722. 150132–150132. 3 indexed citations

Yu, Xiaobo, Xu Zhao, Junqing Liu, et al.. (2022). Investigation of the chemical structure of anti-amyloidogenic constituents extracted from Thamnolia vermicularis. Journal of Ethnopharmacology. 289. 115059–115059. 3 indexed citations

Yu, Xiaobo, et al.. (2020). LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p. International Journal of Immunopathology and Pharmacology. 34. 1682196195–1682196195. 14 indexed citations

Yu, Xiaobo, et al.. (2019). Degradation of CCNB1 mediated by APC11 through UBA52 ubiquitination promotes cell cycle progression and proliferation of non-small cell lung cancer cells.. PubMed. 11(11). 7166–7185. 35 indexed citations

Zhao, Li, et al.. (2017). FKBP3 Promotes Proliferation of Non-Small Cell Lung Cancer Cells through Regulating Sp1/HDAC2/p27. Theranostics. 7(12). 3078–3089. 50 indexed citations

Yu, Xiaobo, Qiang Lin, Zheng Ruan, et al.. (2016). ACE2 Antagonizes VEGFa to Reduce Vascular Permeability During Acute Lung Injury. Cellular Physiology and Biochemistry. 38(3). 1055–1062. 40 indexed citations

Shen, Hua, Xiaobo Yu, Fengming Yang, et al.. (2016). Reprogramming of Normal Fibroblasts into Cancer-Associated Fibroblasts by miRNAs-Mediated CCL2/VEGFA Signaling. PLoS Genetics. 12(8). e1006244–e1006244. 79 indexed citations

Yu, Xiaobo, Haihua Huang, Xi Chen, et al.. (2016). Upregulation of microRNA-450 inhibits the progression of lung cancer in vitro and in vivo by targeting interferon regulatory factor 2. International Journal of Molecular Medicine. 38(1). 283–290. 18 indexed citations

Zhao, Li, et al.. (2016). Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells. Oncotarget. 7(38). 61366–61377. 36 indexed citations

10.

Shen, Hua, Lin Wang, Xin Ge, et al.. (2016). MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer. Oncotarget. 7(15). 20728–20742. 56 indexed citations

11.

Yu, Xiaobo, Qiang Lin, Qin Xiong, et al.. (2015). Serum and glucocorticoid kinase 1 promoted the growth and migration of non-small cell lung cancer cells. Gene. 576(1). 339–346. 31 indexed citations

12.

Yu, Xiaobo, et al.. (2014). Efficacy of early postoperative enteral nutrition in supporting patients after esophagectomy.. PubMed. 69(1). 37–46. 35 indexed citations

13.

Zhang, Wu, Liming Chen, Fei Chen, et al.. (2013). MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma. Journal of Translational Medicine. 11(1). 195–195. 70 indexed citations

14.

Bin, Xu, et al.. (2010). Comparative Study on the Quality of Poria Cocos from 20 Different Origin Places. Zhongguo zhongyiyao xinxi zazhi. 17(8). 34–36. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact